Isolation of an antineoplastic protein fraction and an antineoplastic peptide fraction from human urine
AssigneeThe University of Tennessee Research Corporation
InventorNathan H. Sloane
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe University of Tennessee Research Corporation
InventorNathan H. Sloane
Estimating the term…
The passage of human urine through a bed of adsorbent material results in the adsorption from the urine of antineoplastic substances as determined by in vitro tissue culture techniques utilizing human tumor cells. The adsorbent yields two antineoplastic fractions upon sequential elution. Elution of the low-molecular weight antineoplastic fraction is accomplished by elution with cold aqueous acetone at slightly alkaline pH. Thereafter, elution of the high molecular weight antineoplastic fraction is accomplished by elution with a cold aqueous acetone-glycerol mixture at slightly alkaline pH. The antineoplastic activities of these fractions are determined by tissue culture techniques employing a variety of human neoplastic cells. Furthermore, the high molecular weight fraction, the antineoplastic urinary protein, also inhibits the progression and causes regression of certain human tumor cells implanted in the nude mouse.
A method for extracting a glycoprotein fraction including a glycoprotein having a molecular weight of between about 20,000 Daltons and about 40,000 Daltons, said protein exhibiting antineoplastic activity, from human urine containing said glycoprotein fraction, said method comprising contacting a magnesium silicate adsorbent with human urine, washing non-adsorbed urine from said adsorbent, and eluting said glycoprotein fraction from said adsorbent with a mixture of aqueous acetone and glycerol comprising about 15% aqueous acetone containing about 30% glycerol at a pH of between about 8.5 and about 9.5.
A glycoprotein, having a molecular weight of between about 20,000 Daltons and about 40,000 Daltons extracted from human urine by contacting a magnesium silicate adsorbent with human urine, washing non-adsorbed urine from said adsorbent and eluting said glycoprotein from said adsorbent with a mixture of aqueous acetone and glycerol, comprising about 15% aqueous acetone containing about 30% glycerol at a pH of between about 8.5 and about 9.5, said glycoprotein exhibiting antineoplastic activity in human tumor cell lines.
Dependencies are inferred from the claim text.